Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatin

No abstract is available for this paper.

• Publication year

  1984

• Venue

  Cancer

• Publication date

  1984-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19841101)54:9<1983::AID-CNCR2820540933>3.0.CO;2-2PMID 6548172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancer.

  1983cited by this paper
• Chemotherapy of advanced ovarian carcinoma: Initial experience using a platinum‐based combination

  1982cited by this paper
• BMDP-79, biomedical computer programs, P-series

  1981cited by this paper
• Improved chemotherapy for ovarian cancer with cis‐diamminedichloroplatinum and adriamycin

  1981cited by this paper
• Fine-needle aspiration cytology in the management of gynecologic cancer.

  1981cited by this paper
• cis-Platinum in gynecologic cancer. I. Epithelial ovarian cancer.

  1981cited by this paper
• cis-Platinum in gynecologic cancer

  1981cited by this paper
• Chemotherapy of Recurrent Ovarian Carcinoma with cis‐Dichlorodiammine Platinum II and Adriamycin

  1980cited by this paper
• cis-Diamminedichloroplatinum(II) therapy for advanced ovarian cancer.

  1980cited by this paper
• Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide: a preliminary report.

  1979cited by this paper
• Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.

  1979cited by this paper
• cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.

  1979cited by this paper
• cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.

  1978cited by this paper
• [Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)].

  1978cited by this paper
• Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapy.

  1978cited by this paper
• Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.

  1978cited by this paper
• Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.

  1976cited by this paper
• Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.

  1975cited by this paper
• The chemotherapy of ovarian carcinoma

  1974cited by this paper
• Chemotherapy in the treatment of cancer of the ovary.

  1971cited by this paper
• Cardiovascular alterations in toxemia.

  1970cited by this paper
• Chemotherapy in the treatment of cancer of the ovary

  1970cited by this paper
• Fetal Losses in Hypertension and in Preeclampsia: Part II. Prognosis for the fetus according to the week of gestation

  1954cited by this paper

• Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer

  2004cites this paper
• Combination effect of AC‐7700, a novel combretastatin A‐4 derivative, and cisplatin against murine and human tumors in vivo

  2003cites this paper
• Impact of Residual Tumor on Survival of Patients with Advanced Stage Common Epithelial Ovarian Cancer at King Chulalongkorn Memorial Hospital from 1995 to 1999

  2002cites this paper
• Effects of Social Housing Condition on Chemotherapeutic Efficacy in a Shionogi Carcinoma (SC115) Mouse Tumor Model: Influences of Temporal Factors, Tumor Size, and Tumor Growth Rate

  2001cites this paper
• Influences of social housing conditions on chemotherapeutic efficacy : tumor, host and temporal factors

  2000cites this paper
• Prognostic Value of CA125 Kinetics and Half-Life in Advanced Ovarian Cancer

  2000cites this paper
• Evaluation of cytoreductive surgery with pelvic and paraaortic lymphadenectomy and intermittent cisplatin-based combination chemotherapy for improvement of long-term survival in ovarian cancer.

  1999cites this paper
• Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide.

  1997cites this paper
• Primary debulking surgery in advanced ovarian carcinoma

  1996cites this paper
• Meta-analysis comparing cisplatin total dose intensity and survival.

  1995cites this paper
• Carboplatin in combination with epirubicin and cyclophosphamide in patients with advanced ovarian cancer. A phase II study.

  1995cites this paper
• Intermittent Intensive Combination Chemotherapy with Cisplatin, Doxorubicin, and Cyclophosphamide (Cyclic PAC Chemotherapy) for Ovarian Cancer

  1992cites this paper
• Tumor debulking followed by immediate combination chemotherapy in advanced ovarian carcinoma: Phase II

  1992cites this paper
• Efficacy and toxicity of very high-dose cisplatin in advanced ovarian carcinoma: 4-year survival analysis and neurological follow-up

  1992cites this paper
• Meta-Analysis of Cisplatin, Doxorubicin, and Cyclophosphamide Versus Cisplatin and Cyclophosphamide Chemotherapy of Ovarian Carcinoma

  1992cites this paper
• A phase II trial of intraperitoneal cisplatin and etoposide for primary treatment of ovarian epithelial cancer.

  1990cites this paper
• A pilot study investigating intraoperative electron beam irradiation in the treatment of ovarian malignancies.

  1990cites this paper
• Serum albumin: its relationship to marrow and renal toxicity from platinum-based combination chemotherapy.

  1990cites this paper
• Management of epithelial ovarian neoplasms using a platinum‐based regimen: A 10‐year experience

  1990cites this paper
• Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients.

  1990cites this paper
• Management of epithelial ovarian neoplasms using a platinum-based regimen: a 10-year experience.

  1990cites this paper
• Predictive factors for long-term survival in patients with advanced ovarian cancer.

  1989cites this paper
• The feasibility of early administration of combination chemotherapy following cytoreductive surgery and second-look operation in patients with stage III ovarian carcinoma: a pilot study.

  1989cites this paper
• Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.

  1988cites this paper
• Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor.

  1988cites this paper
• Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma.

  1988cites this paper
• Concordance of combination and single agent chemosensitivity prediction in ovarian carcinoma using the subrenal capsule xenograft assay (SRCA).

  1988cites this paper
• Questioning current policies for the curative management of ovarian carcinoma.

  1988cites this paper
• Treatment of advanced ovarian cancer with sequential combination chemotherapy

  1987cites this paper
• Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.

  1987cites this paper
• Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma.

  1987cites this paper
• Speed of response to platinum-based chemotherapy: implications for the management of epithelial ovarian cancer.

  1987cites this paper
• Ovarian carcinoma: results of radiation therapy and chemotherapy in 83 patients.

  1987cites this paper
• Randomized trial of megestrol acetate vs. megestrol acetate/tamoxifen for the management of progressive or recurrent epithelial ovarian carcinoma.

  1987cites this paper
• Hexamethylmelamine, methotrexate, 5-fluorouracil as second line chemotherapy after platinum for epithelial ovarian malignancies.

  1986cites this paper
• The Norton-Simon hypothesis revisited.

  1986cites this paper
• Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin.

  1986cites this paper
• [Therapeutic effectiveness of various combination chemotherapy protocols in advanced epithelial ovarian cancer].

  1986cites this paper
• False‐Negative Peritoneal Cytology in Metastatic Ovarian Carcinoma

  1986cites this paper
• Implications of kinetic heterogeneity in clinical oncology.

  1985cites this paper
• The effect of cytoxan, adriamycin, and cis-platinum on cervical, vaginal cytology.

  1985cites this paper
• Stage I carcinoma of the endometrium: a 5-year experience utilizing preoperative cesium.

  1985cites this paper